Walleye Capital LLC Immunocore Holdings PLC Call Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$33.78 - $63.75 $3,378 - $6,375
100 Added 4.17%
2,500 $84,000
Q1 2024

May 15, 2024
SELL
$60.14 - $75.36 $126,294 - $158,256
-2,100 Reduced 46.67%
2,400 $156,000
Q4 2023

Feb 14, 2024
BUY
$42.85 - $69.5 $98,555 - $159,850
2,300 Added 104.55%
4,500 $307,000
Q3 2023

Nov 14, 2023
BUY
$49.5 - $66.6 $108,900 - $146,520
2,200 New
2,200 $114,000

Others Institutions Holding IMCR

# of Institutions
141
Shares Held
41.4M
Call Options Held
197K
Put Options Held
451K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.39B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email